Quarterly snapshots from biopharma companies with marketed products: Genmab, Johnson & Johnson

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aruvant, Baudax Bio, Celularity, Genprex, Inhibitor, Jazz, Ra, Supernus

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allergan, Apexian, Astrazeneca, Axim, Basilea, Bavarian Nordic, Biocartis, Celavie, Genialis, Inotrem, Ironwood, Jazz, Ocuphire, Oncologie, Pharmacyte, Pharmamar, Proteostasis, Roche, Sapphire, Sarepta, Sierra, Zhittya Genesis

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Axsome, Cytodyn, LB Pharmaceuticals, Metacrine, Moberg, Neurotrope, Vaxart

Biopharmas raising money in public or private financings: Adaptimmune, Applied Therapeutics, Chi-Med, Cidara, Heat, Immuneering, Nanoviricides, Zai Lab, Zymeworks

New hires and promotions in the biopharma industry: Cohbar, Dermavant, Impel, Oncosec

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications.

New hires and promotions in the biopharma industry in Asia-Pacific.

Biopharma happenings in Asia-Pacific, including deals and partnerships, grants, preclinical data and other news in brief.